诚意药业(603811.SH)：二十碳五烯酸乙酯软胶囊获得药品注册证书

Core Viewpoint - Chengyi Pharmaceutical (603811.SH) has received approval from the National Medical Products Administration for the registration certificate of Eicosapentaenoic Acid Ethyl Ester Soft Capsules, aimed at reducing triglyceride levels in adult patients with severe hypertriglyceridemia (≥500 mg/dL) [1] Group 1 - The product is intended for use in conjunction with dietary control to lower triglyceride levels in patients with severe hypertriglyceridemia [1] - It is also indicated for adult patients with confirmed cardiovascular disease or diabetes with two or more other cardiovascular risk factors, combined with hypertriglyceridemia (≥150 mg/dL), to reduce the risk of cardiovascular events such as myocardial infarction, stroke, coronary artery revascularization, and unstable angina requiring hospitalization [1] - The impact of this product on the risk of pancreatitis in patients with severe hypertriglyceridemia has not yet been evaluated [1]